Search by Drug Name or NDC

    NDC 55513-0546-10 NEUPOGEN 480 ug/1.6mL Details

    NEUPOGEN 480 ug/1.6mL

    NEUPOGEN is a INTRAVENOUS; SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amgen Inc. The primary component is FILGRASTIM.

    Product Information

    NDC 55513-0546
    Product ID 55513-546_2eacc44a-29a9-49e6-a93e-63aa38725478
    Associated GPIs 82401520002012
    GCN Sequence Number 046004
    GCN Sequence Number Description filgrastim VIAL 480MCG/1.6 INJECTION
    HIC3 N1C
    HIC3 Description LEUKOCYTE (WBC) STIMULANTS
    GCN 13206
    HICL Sequence Number 006070
    HICL Sequence Number Description FILGRASTIM
    Brand/Generic Brand
    Proprietary Name NEUPOGEN
    Proprietary Name Suffix n/a
    Non-Proprietary Name Filgrastim
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS; SUBCUTANEOUS
    Active Ingredient Strength 480
    Active Ingredient Units ug/1.6mL
    Substance Name FILGRASTIM
    Labeler Name Amgen Inc
    Pharmaceutical Class Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA103353
    Listing Certified Through 2024-12-31

    Package

    NDC 55513-0546-10 (55513054610)

    NDC Package Code 55513-546-10
    Billing NDC 55513054610
    Package 10 VIAL in 1 BOX (55513-546-10) / 1.6 mL in 1 VIAL (55513-546-01)
    Marketing Start Date 1997-04-07
    NDC Exclude Flag N
    Pricing Information N/A